Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sevil Yasar

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Addiction Biology|November 9, 2010
Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonistZuzana Justinová, Sergi Ferré, Godfrey H Redhi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2025
Clinical factors predicting the rate of cognitive decline in a US memory clinic: An electronic health record studyRoy Adams, Jeannie-Marie Leoutsakos, Milap A Nowrangi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 18, 2011
Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory studyKerstin Bettermann, Alice M Arnold, Jeff Williamson, et al.
Frontiers in Neurology|April 17, 2023
INPH and parkinsonism: A positive shunt response with a negative tap testGiulia Giannini, Ignacio Jusue-Torres, Paolo Mantovani, et al.
Neuropharmacology|October 2, 2007
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibitionMaria Scherma, Julie Medalie, Walter Fratta, et al.
Archives of Internal Medicine|July 15, 2009
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health StudyKaycee M Sink, Xiaoyan Leng, Jeff Williamson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 13, 2004
Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratoryLeigh V Panlilio, Sevil Yasar, Ro Nemeth-Coslett, et al.
Addiction Biology|January 24, 2012
Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeysCharles W Schindler, Zuzana Justinova, David Lafleur, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 26, 2025
Hearing Loss, Hearing Aid Use, and Neuropsychiatric Symptoms Among Persons Living With Dementia: Findings From NACCAhjeetha Shankar, Emmanuel E Garcia Morales, Jeannie-Marie Leoutsakos, et al.
Annals of Neurology|May 27, 2021
Blood-Brain Barrier Breakdown in Relationship to Alzheimer and Vascular DiseaseZixuan Lin, Sandeepa Sur, Peiying Liu, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Addiction Biology|November 9, 2010
Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonistZuzana Justinová, Sergi Ferré, Godfrey H Redhi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2025
Clinical factors predicting the rate of cognitive decline in a US memory clinic: An electronic health record studyRoy Adams, Jeannie-Marie Leoutsakos, Milap A Nowrangi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 18, 2011
Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory studyKerstin Bettermann, Alice M Arnold, Jeff Williamson, et al.
Frontiers in Neurology|April 17, 2023
INPH and parkinsonism: A positive shunt response with a negative tap testGiulia Giannini, Ignacio Jusue-Torres, Paolo Mantovani, et al.
Neuropharmacology|October 2, 2007
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibitionMaria Scherma, Julie Medalie, Walter Fratta, et al.
Archives of Internal Medicine|July 15, 2009
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health StudyKaycee M Sink, Xiaoyan Leng, Jeff Williamson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 13, 2004
Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratoryLeigh V Panlilio, Sevil Yasar, Ro Nemeth-Coslett, et al.
Addiction Biology|January 24, 2012
Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeysCharles W Schindler, Zuzana Justinova, David Lafleur, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 26, 2025
Hearing Loss, Hearing Aid Use, and Neuropsychiatric Symptoms Among Persons Living With Dementia: Findings From NACCAhjeetha Shankar, Emmanuel E Garcia Morales, Jeannie-Marie Leoutsakos, et al.
Annals of Neurology|May 27, 2021
Blood-Brain Barrier Breakdown in Relationship to Alzheimer and Vascular DiseaseZixuan Lin, Sandeepa Sur, Peiying Liu, et al.
Pageof 12